The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients

Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease

Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease

Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic

Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis—a cross-sectional study

Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review